Results 11 to 20 of about 732,366 (171)

Functional Tricuspid Regurgitation in the Transcatheter Aortic Valve Replacement Population and Emerging Transcatheter Tricuspid Valve Interventions [PDF]

US Cardiology Review
Transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic valve disease. However, its success has brought attention to concurrent tricuspid valve disease and the inadequacy of treatments.
Molly Silkowski, Payton Kendsersky, Nicholas Amoroso   +2 more
doaj   +2 more sources

Transcatheter Tricuspid Valve-In-Ring and Aortic Valve-In-Valve Implantation

The Thoracic & Cardiovascular Surgeon Reports, 2017
Background Transcatheter heart valve (THV) therapies have shown to be an alternative to surgical valve replacement, especially in high-risk patients requiring redo surgery. However, reports of transcatheter-based interventions in tricuspid valve position
Daniel Reichart, Niklas Schofer, Florian Deuschl, Andreas Schaefer, Stefan Blankenberg, Hermann Reichenspurner, Ulrich Schaefer, Lenard Conradi   +7 more
doaj   +2 more sources

Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß, Philipp Mourikis, Fabian Nienhaus, Jafer Haschemi, Alexander Hoss, Tobias Zeus, Hanna Kowalski, Maximilian Spieker, Christian Jung, Patrick Horn, Hug Aubin, Artur Lichtenberg, Richard Truse, Malte Kelm, Amin Polzin   +14 more
wiley   +2 more sources

Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review

Reviews in Cardiovascular Medicine
Medical devices for tricuspid regurgitation have emerged as viable treatment options for patients who do not respond to drug therapy or who are unsuitable for open-heart surgery due to high surgical risk.
Sara Veneziano, Sabrina Trippoli, Andrea Messori, Vincenzo Calderone, Eugenia Piragine   +4 more
doaj   +2 more sources

ANTecedent Annular Reduction to Facilitate TransCatheter TrICuspid Valve Replacement (ANTARCTIC). [PDF]

JACC Case Rep
BACKGROUND: Transcatheter tricuspid valve implantation may not be possible when annular size is very large. CASE SUMMARY: We present an 85-year-old man who developed NYHA functional class III symptoms and recurrent heart failure hospitalizations due to ...
Jabri A, Madanat L, Bloomingdale R, Foglesong A, Abbas A, Renard B, Horstmanshof D, Hanson ID.   +7 more
europepmc   +2 more sources

Transcatheter Tricuspid Valve Replacement: Current Options and Future Perspectives [PDF]

Reviews in Cardiovascular Medicine
Tricuspid regurgitation (TR) is a potentially lethal condition and represents a significant clinical challenge both for clinical and interventional cardiologists. Traditionally managed medically and surgically, transcatheter therapies are now an emerging
Guido Del Monaco, Gianluca Mincione, Alessandro Sticchi, Bernhard Reimers, Antonio Colombo, Antonio Mangieri   +5 more
doaj   +2 more sources

Transcatheter treatment for tricuspid valve disease. [PDF]

, 2021
Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve apparatus and is observed in only 8-10% of the patients with tricuspid valve ...
Maisano, Francesco, Praz, F., Kreidel, F., Mangieri, A., Prendergast, B.D., Muraru, Denisa, Hahn, Rebecca T, Zamorano, Jose L, Mangieri, Antonio, Zamorano, J.L., von Bardeleben, Ralph Stephan, Hausleiter, Jörg, Maisano, F., Nickenig, G., Prendergast, Bernard D, Bardeleben, R.S. von, Senni, Michele, Nickenig, Georg, Delgado, V., Praz, Fabien, Lurz, P., Senni, M., Delgado, Victoria, Hausleiter, J., Lurz, Philipp, Hahn, R.T., Kreidel, Felix, Muraru, D.   +27 more
core   +2 more sources

Potential Candidates for Transcatheter Tricuspid Valve Intervention After Transcatheter Aortic Valve Replacement: Predictors and Prognosis. [PDF]

, 2021
OBJECTIVES The aims of this study were to document the prevalence of concomitant tricuspid regurgitation (TR) before and after transcatheter aortic valve replacement (TAVR), to quantify potential eligibility for transcatheter tricuspid valve ...
Heg, Dik, Lanz, Jonas, Windecker, Stephan, Tomii, Daijiro, Praz, Fabien, Reineke, David, Pilgrim, Thomas, Okuno, Taishi, Stortecky, Stefan, Wild, Mirjam Gauri   +9 more
core   +4 more sources

Transcatheter Tricuspid Valve Intervention: Current Perspective

US Cardiology Review, 2021
Tricuspid regurgitation (TR) adversely impacts both quality of life and long-term survival, which generates interest in therapeutic approaches to mitigate these effects.
Trevor J Simard, Mackram F Eleid
doaj   +1 more source

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias, Schoenermarck, Ulf, Rau, Simon, Fischereder, Michael, Steinbeck, Gerhard, Kupatt, Christian, Lange, Philipp   +6 more
core   +1 more source